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Abstract
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in the Western world and
interactions between genetic and environmental factors, including diet, are suggested to play a critical role in its
etiology. We conducted a long-term feeding experiment in the mouse to address gene expression and methylation
changes arising in histologically normal colonic mucosa as putative cancer-predisposing events available for early
detection. The expression of 94 growth-regulatory genes previously linked to human CRC was studied at two time
points (5 weeks and 12 months of age) in the heterozygote Mlh1+/- mice, an animal model for human Lynch syndrome
(LS), and wild type Mlh1+/+ littermates, fed by either Western-style (WD) or AIN-93G control diet. In mice fed with WD,
proximal colon mucosa, the predominant site of cancer formation in LS, exhibited a significant expression decrease
in tumor suppressor genes, Dkk1, Hoxd1, Slc5a8, and Socs1, the latter two only in the Mlh1+/- mice. Reduced mRNA
expression was accompanied by increased promoter methylation of the respective genes. The strongest expression
decrease (7.3 fold) together with a significant increase in its promoter methylation was seen in Dkk1, an antagonist of
the canonical Wnt signaling pathway. Furthermore, the inactivation of Dkk1 seems to predispose to neoplasias in the
proximal colon. This and the fact that Mlh1 which showed only modest methylation was still expressed in both Mlh1+/-
and Mlh1+/+ mice indicate that the expression decreases and the inactivation of Dkk1 in particular is a prominent early
marker for colon oncogenesis.
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Introduction
Colorectal cancer (CRC) evolves as a multistep process,
which requires a series of genetic and epigenetic alterations.
The process is accelerated in individuals with inherited cancer
predisposition, and interactions between genetic and
environmental factors, including diet, seem to be in key position
in its etiology [1,2]. The importance of epigenetic alterations
such as DNA methylation changes in the initiation of CRC is
now acknowledged [3,4], yet, the earliest events in normal
colonic mucosa available for early detection and prevention of
cancer development remain to be elucidated.
Although inherited mutations in the tumor suppressor gene
(TSG) APC (adenomatous polyposis coli), an important
component of the Wnt/β-catenin signaling pathway, and the
mismatch repair (MMR) genes (e.g. MLH1, mutL homolog 1),
which control the mutation rate in a cell [2] may confer a high
lifetime risk of cancer with an early age at onset, colorectal
cancer is clearly a disease of increasing age [3,4]. Accordingly,
methylation changes of a small subset of TSGs have been
detected in the aging colonic mucosa of normal healthy
individuals, and this methylation involves genes which often
become more substantially methylated in neoplastic cells [5-7],
suggesting their role in cancer initiation and progression. Along
with aging some exogenous compounds from dietary sources
are important modifiers of methylation patterns in the colon [8],
probably explaining why Western populations consuming
considerable amounts of red meat, saturated fat and sugar,
and only moderate amounts of dietary fiber, vitamins and
minerals (e.g. calcium, folate, and vitamin D), as well as plant
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derived nutrients show the highest CRC incidences in the world
[1] (World Cancer Research Fund,
www.dietandcancerreport.org). Epigenetic changes thus
provide a potential link between nutrition and cancer [9] and
emphasize the need to elucidate dietary effects on gene
regulation in intestinal mucosa.
Animal models, particularly rodents, provide a valuable
resource in the field of environmental epigenetics including
studies on changes mediated through diet [10]. Results
suggesting that Western-style diet (WD) induces
gastrointestinal tumors in mouse models for familial intestinal
cancer and even in wild-type (WT) mice without any carcinogen
treatment [11-14] prompted us to study the effects of WD
exposures on gene regulation and methylation in normal colon
mucosa with and without inherited colon cancer susceptibility.
We selected 94 growth-regulatory genes previously linked to
human CRC and studied their expression in the heterozygote
Mlh1+/- mice analogous to human Lynch syndrome (LS), and
WT Mlh1+/+ littermates. During a long-term feeding experiment
we used our own modification of Western-style diet (WD*)
which highly resembles the New Western Diet (NWD) shown to
induce benign and malignant neoplasms in the colon of normal
C57Bl/6 mice after an 18 month feeding experiment [12]. The
main difference between NWD and WD* is the fat source which
in WD* was largely changed from oil to animal (milk) fat and
thus resembling more fat consumed by Western populations.
Here, proximal colon, the predominant site of cancer formation
in LS [15], revealed several significant age-related changes in
gene expressions. Some changes were potentiated by WD*
and some were found only in mice with genetic cancer
predisposition. We further demonstrated that the expression
changes detected from the histologically normal mucosa were
remarkably early occurring prior to APC inactivation and the
second hit in Mlh1.
Methods
Mice
Heterozygote B6.129-Mlh1tm1Rak mice (Mlh1+/-) (strain 01XA2)
were obtained from NCI-MMHCC; National Institutes of Health,
Mouse Repository, NCI-Frederick, MD. In B6.129-Mlh1tm1Rak
mice, exon 2 is missing in one of the two Mlh1 alleles leading
to non-functional Mlh1 protein [16]. Mlh1+/- mice have an
increased morbidity compared to their WT littermates and
approximately one third develop tumors such as lymphomas as
well as tumors of the small and large intestine and a number of
other organs during their lifespan [17]. The Mlh1+/- and Mlh1+/+
mice were genotyped using genomic DNA extracted from
earmarks according to the protocol published at the Mouse
Repository website (http://mouse.ncifcrf.gov/protocols.asp?
ID=01XA2&p_allele=Mlh1%3Ctm1Rak%3E&prot_no=1) (See
Materials and Methods S1).
Ethics statement
Mice were bred and treated according to the study protocol
approved by the national Animal Experiment Board in Finland
(ESLH-2008-06502/Ym-23). The mice were humanely
euthanized with CO2 inhalation.
Diets
At the age of 5 weeks (time point 0, tp0), Mlh1+/- and Mlh1+/+
mice were randomly divided into two dietary groups (n = 8/
group, including both sexes) fed with AIN-93G (AIN) control
diet [18] or Western-style (WD*) diet (Harlan Teklad, Madison,
WI) (Table 1, detailed description of diets and their nutritional
compositions are in Table S1).
Sample preparation
Eight mice per each group at tp0 (Mlh1+/-, Mlh1+/+) and tp1
(12 months of age) (Mlh1+/+ AIN, Mlh1+/- AIN, Mlh1+/+ WD*,
Mlh1+/- WD*) 48 mice in total were sacrificed and sampled.
Histological studies were carried out at The Finnish Centre for
Laboratory Animal Pathology (FCLAP), University of Helsinki,
Finland.
For genomic DNA and total RNA extractions, the mucosa (6
x 4 mm) was separated from the underlying submucosa and
musculature under a dissecting microscope. Samples for RNA
extraction were stored in RNAlater (Qiagen, Valencia, CA) at
-80°C.
RNA extraction and reverse transcription
The total RNA samples were prepared using the RNeasy
Plus Kit (Qiagen, Valencia, CA) with an extra Dnase treatment
(Qiagen, Valencia, CA). The RNA integrity was analyzed with
the Agilent 2100 Bioanalyzer (Agilent technologies, Santa
Clara, CA) and only high quality RNA (RNA integrity number
RIN > 8) was used for cDNA synthesis reactions, which were
ran as duplicates and pooled for the RT-qPCR reactions.
Reverse transcription from either 200 ng (individual samples for
StellARray) or 1600 ng (pools of eight samples, 200 ng each,
Table 1. Diet nutritional information.
 AIN93-G WD*
Fat Sources (g/kg)a (g/kg)b
Soybean Oil 70 -
Anhydrous Milkfat - 133
Canola Oil - 55
Sunflower Oil - 12
Carbohydrate Sources   
Starch 397 306
Maltodextrin 132 95
Sucrose 100 116
Protein Source 200 (Casein) 232 (Casein, vitamin free)
Total energy content (kcal/g) 3.8 4.6
Kcal from fat (%) 17.2 39.2
Kcal from carbohydrates (%) 63.9 42.3
Kcal from protein (%) 18.8 18.5
Vitamin D (IU/kg) 1000 100
Folic acid (mg/kg) 2 0.2
Calcium 5 0.5
For detailed composition of the experimental diets see Table S1.
a If not stated differently
b If not stated differently
doi: 10.1371/journal.pone.0076865.t001
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from eight different mice belonging to each tp1 group for
TaqMan RT-qPCR) of total RNA was achieved with M-MuLV
RNase H+ (Thermo Scientific, Finland) or Superscript III (Life
technologies, Carlsbad, CA), respectively, using random
primers according to the manufacturers’ instructions.
RNA expression studies
The RNA expressions of histologically normal tissue samples
from proximal colonic mucosa were analyzed by using a
quantitative custom made StellARrayTM platform (Lonza Group
Ltd, Bar Harbor BioTechnology). The StellARray included 94
genes (73 TSGs) previously associated with development of
colorectal cancer and/or documented to exhibit CpG island
(CGI) hypermethylation in CRC and other human cancers
(Table S2). APC was included in the array as an indicator of
ongoing carcinogenesis. Eight mice from each study group
were separately analyzed for the expression of the 94 genes of
interest (48 RT-qPCR arrays in total).
Each StellARray plate well was loaded with 20 µl of SYBR
Green master mix containing 8µl of sample specific cDNA and
modified Thermus brockianus DNA polymerase (Thermo
Scientific, Finland). The RT-qPCR arrays were run on a
Mx3000P cycler (Agilent technologies, Santa Clara, CA) using
the following cycling parameters: 50°C for 2 min, 95°C for 7
min, 40 cycles of 95°C for 15 s, and 60°C for 1 min.
Fluorescence data was acquired during the 60°C annealing/
extension step. The primer specificity was monitored through a
melting curve analysis. The expression differences between
different mouse groups were analyzed using the Global Pattern
Recognition™ (GPR) software (Bar Harbor Biotechnology,
Trenton, ME)
The results of statistically significant expression changes in
relation to WD* and/or inherited cancer predisposition were
validated at tp1 using TaqMan assays (Table S3). In contrast to
StellARray RT-qPCR, the TaqMan RT-qPCR analysis was
done from pooled samples. Each pooled sample was assayed
in triplicate for the target genes, as well as the endogenous
reference genes using the following cycling parameters: 1 cycle
of 95°C for 10 min, 40 cycles of 95°C for 15 s, and 60°C for 1
min. Thermal cycling and fluorescence data acquisition were
performed with a StepOnePlus cycler (Life Technologies,
Carlsbad, CA) and Cq values were called using the Data-assist
v2.0 software (Life Technologies, Carlsbad, CA). The uniformly
expressed reference genes (Hdac1 and Stk4) were selected
using the GeNorm algorithm [19] from amongst the 94 genes
included in the StellARray. Mlh1 expression levels at tp0 were
also quantitated using TaqMan assay.
If the amount of template was too low to give reliable results,
the RT-qPCR validation was performed using pre-amplified
cDNA. For each tp1 group, pooled samples were multiplex pre-
amplified using 16 ng of cDNA with TaqMan PreAmp Master
Mix Kit (Life Technologies, Carlsbad, CA) following
manufacturer’s instructions. The cycling parameters were as
follows: 1 cycle of 95°C for 10 min and 10 pre-amplification
cycles of 95°C for 15 s, and 60°C for 4 min.
DNA methylation analysis
For the DNA methylation analysis, only the genes which had
shown a significant mRNA expression decrease (i.e. candidate
hypermethylated TSGs) in association with inherited
predisposition and/or WD* were selected, and the methylation
levels of their CpG islands (CGIs) were assessed individually
for each tp0 and tp1 mouse. Genomic DNA for the methylation
analysis was extracted using DNeasy Blood & Tissue Kit
(Qiagen, Valencia, CA) from tissue samples from the
immediate vicinity of those used for RNA expression studies.
The quantitative methylation analysis was performed with
Sequenom’s MassARRAY EPITYPERTM system (Sequenom
GmbH, Hamburg, Germany) which is a bisulphate-based
technology relying on base-specific cleavage of RNA and
matrix-assisted laser desorption ionization time-of-flight mass
spectrometry (MALDI-TOF-MS) to determine the relative extent
of methylation in DNA fragments containing either one or
several subsequent CpG sites, which are referred to as CpG
units [20]. In the mass spectrum, a distinct signal pattern
results from the methylated and non-methylated target
sequence, and the EPITYPER software determines the
individual methylation ratios (i.e. signal intensity ratios as
percentage of methylated to non-methylated signals) for CpG
sites/unit within a target sequence. The system is able to detect
methylation levels as low as 5%.
The amplicons were primarily selected to cover CGIs
annotated by the UCSC genome browser and to be
overlapping with the transcription start site and the 5’ UTR or
be in their close proximity. Altogether, twelve different
amplicons (lengths between 174 and 499 bp) were analyzed of
which eight belonged to the pre-validated Mouse Standard
EpiPanel and four were custom DNA methylation assays
designed using Sequenom’s EpiDESIGNER software
(Sequenom GmbH, www.epidesigner.com), for which primer
sequences and target sites are provided in Table S4. In order
to reduce methylation variability introduced during PCR [21],
three replicate amplifications were performed and pooled for
mass analysis. The initial methylation data was filtered by
Sequenom to exclude poor quality measurements. CpG units
that yielded data in greater than 75% of the samples passed
the initial quality control. From these, samples that yielded data
in greater than 80% for all CpG units within an amplicon were
selected for that sample/amplicon pair. For further analysis,
CpG units which had data available for less than 50% of all
samples and samples which had data available for less than
50% of all CpG units were excluded. After quality control 78%
of the CpG units analyzed (152 out of 196) and all the 48
samples were included in further analysis steps.
Statistical analyses
In StellARray RT-qPCR, a common threshold was set across
all the 48 plates within the experiment. The expression
differences between different groups were analyzed using the
Global Pattern Recognition™ (GPR) software, which executes
efficiency correction and reference gene and control group
normalizations (www.bhbio.com/BHB/dw/products.gpr.html).
GPR also takes advantage of biological replicates to extract
significant changes in gene expression. The StellARray system
Diet-Induced Cancer-Predisposing Events in Colon
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does not work with user defined reference genes. Instead, the
GPR software algorithm determines the best set of reference
genes within the experiment by comparing the expression of all
of the genes included in the assay between test and control
samples, generates a global pattern of expression changes,
and creates a ranked list of significant changes [22]. In this way
the selection of reference genes is unbiased since it enables
the experimental data to define the stably expressed reference
genes.
In TaqMan assays, relative mRNA expression changes were
analyzed using the comparative Ct (ΔΔCt) method, which
presents the data as fold changes in gene expression
normalized to endogenous reference genes and relative to the
control group [23]. Data-assist v2.0 software (Life
Technologies, Carlsbad, CA) was used for quality control and
normalization of the quantification cycle (Cq) data, and a
median permutation method [24] was used to determine the
significance of the expression fold changes compared to the
control group with significance level of P < 0.05.
The correlation between the StellARray expression patterns
of 5 week old Mlh1+/+ and Mlh1+/- mice was studied using
Pearson correlation analysis (R value) of the PASW Statistics
18 system.
Chipster software [25] was used to visualize and analyze the
methylation data. The Non-metric Multi-Dimensional Scaling
(NMDS) tool was used to produce two-dimensional maps
based on sample dissimilarity calculated using Euclidean
distance, and the Dendrogram tool was used to create
dendrograms of samples using normalized data with Pearson
correlation and average linkage method. For Chipster
analyses, missing methylation values of individual CpG units
were defined as the median value of the CpG unit within the
particular mouse group.
Comparison of the average methylation levels between
different mouse groups was performed using Mann-Whitney
test of the PASW Statistics 18 system.
Results
Colonic neoplasias develop predominantly in WD* mice
Overall, one proximal adenocarcinoma and five adenomas/
hyperplastic polyps were observed in the 32 mice at tp1. The
significance of WD* on CRC risk in our mouse series is
highlighted by the fact that 5 out of 6 mice with neoplasias were
fed with WD* and that WD* caused tumor development also in
wild-type mice without inherited predisposition, i.e. the only
carcinoma and one adenoma were found in the Mlh1+/+ WD*
mice (Table 2, Figure S1). The single AIN fed mouse
developing neoplasia (hyperplastic polyp) was a mutation
carrier.
Mlh1+/- and Mlh1+/+ mice show similar mRNA expression
patterns at the outset
At the beginning of the experimental feeding period (tp0), the
Mlh1+/- and Mlh1+/+ mice showed a remarkably good correlation
(Pearson’s R = 0.989, P < 0.01) between the mRNA
expression patterns of the 94 genes included in the custom
StellARray RT-qPCR array (Figure S2A). However, distinct
from the other genes, but in accordance with the different
genotypes, the expression of Mlh1 was approximately 50%
lower in the heterozygote mice than in the WT mice (Figure
S2B). Overall, an isogenic background in the beginning made it
justified to reason that expression differences that would
appear between the different mice groups later were acquired
and not the outcome of the inherited genetic constitution.
WD* and/or inherited predisposition are associated
with differential expression of several genes at tp1
At the age of 12 months (tp1), the expression of several
genes was found to be increased or decreased as compared to
tp0 (Tables 3 and 4). All GPR results (P-values and fold
changes) of expression differences between different mice
groups for all the 94 genes are in Table S5. Nine out of the 94
genes showed statistically significant (P < 0.05) expression
changes between tp0 and tp1 in all mice groups (Mlh1+/+ AIN,
Mlh1+/- AIN, Mlh1+/+ WD*, Mlh1+/- WD*) (Table 3). Decreased
mRNA levels were seen in Ccnd1 (Cyclin D1), Cdh1 (Cadherin
1), and Mal (Myelin and lymphocyte protein, T cell
differentiation protein), while increased expression was seen in
Axin2, Cdx1 (Caudal type homeobox 1), Fzd10 [Frizzled
homolog 10 (Drosophila)], Mbd2 (Methyl-CpG binding domain
protein 2), Mbd4 (Methyl-CpG binding domain protein 4), and
Rasgrf2 (Ras protein-specific guanine nucleotide releasing
factor 2). Since these changes did not depend on inherited
predisposition or WD* they can be attributable to aging.
Statistically significant expression changes between tp0 and
tp1 associated with inherited cancer predisposition (Mlh1+/-)
and/or WD* were observed in seven genes (Table 4, Table
S5); decreased expression in Dkk1 [Dickkopf homolog 1
(Xenopus laevis)], Slc5a8 [(Solute carrier family 5 (iodide
transporter), member 8], Hoxd1 (Homeobox D1), and Socs1
(Suppressor of cytokine signalling 1), and increased expression
in Dkk2 [Dickkopf homolog 2 (Xenopus laevis)], Rprm
(Reprimo, TP53 dependent G2 arrest mediator candidate), and
Acaa1b (acetyl-Coenzyme A acyltransferase 1B).
The strongest expression decrease (7.3 fold) was seen in the
Wnt signaling suppressor gene Dkk1 among the Mlh1+/- mice
fed with WD*. In heterozygote mice fed with AIN and in WT
mice fed with WD*, the decrease was 5.1 and 6.2 fold,
respectively. Interestingly, the homeobox gene Hoxd1 showed
an age-related expression decrease (2.1 fold) only in the
Mlh1+/+ WD* group, and the statistically significant decrease
related to WD* was further observed when this group was
Table 2. Dkk1 inactivation and colonic neoplasias in
different mouse groups.
Mouse Group Dkk1 expressed (n = 16) Dkk1 not expressed (n = 16)
Mlh1+/+ AIN 6 2
Mlh1+/- AIN 3a 5
Mlh1+/+ WD* 4b 4c
Mlh1+/- WD* 3 5a,b,bd
a hyperplastic polyp; b adenoma; c adenocarcinoma; d not histologically confirmed
doi: 10.1371/journal.pone.0076865.t002
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compared with the control group (Mlh1+/+ AIN) at tp1 (1.9 fold)
(Table S5). The expression decrease of the transporter of
butyrate Slc5a8 associated only with the Mlh1 heterozygosity
(1.5 and 1.7 fold in WD* and AIN groups, respectively),
whereas Socs1, a cytokine signaling regulator, was
significantly down regulated (3.1 fold) only if both risk factors
were present, i.e. in the Mlh1+/- WD* group.
The expression of Dkk2, another Wnt signaling modulator,
was significantly increased in the Mlh1+/- AIN group (Table 4)
so that at tp1, Dkk2 expression among Mlh1+/- mice was
significantly lower (2.2 fold) in the WD* group compared to the
AIN group (Table S5). Rprm showed a statistically significant
age-related expression increase in association with Mlh1
heterozygosity (3.3 and 2.0. fold in WD* and AIN, respectively).
Table 3. Genes showing statistically significant (P < 0.05)
mRNA expression differences between tp0 and tp1 in all
four mouse groups; in the control group (Mlh1+/+ AIN) and
the three study groups (Mlh1+/- AIN, Mlh1+/+ WD, Mlh1+/-
WD).
 Mlh1+/+ AIN Mlh1+/- AIN Mlh1+/+ WD Mlh1+/- WD
Downregulated
Genes
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Ccnd1 3.3 (0.003) 3.8 (0.000) 4.3 (0.001) 3.6 (0.000)
Cdh1 5.4 (0.002) 4.9 (0.000) 5.9 (0.002) 8.4 (0.000)
Mal 3.4 (0.025) 3.4 (0.014) 3.2 (0.034) 2.7 (0.028)
Upregulated
Genes
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Axin2 2.6 (0.005) 3.0 (0.002) 1.8 (0.039) 1.6 (0.028)
Cdx1 4.1 (0.002) 5.6 (0.000) 3.4 (0.002) 5.4 (0.000)
Fzd10 4.8 (0.002) 7.6 (0.000) 3.4 (0.021) 5.0 (0.000)
Mbd2 3.3 (0.004) 4.7 (0.000) 3.2 (0.003) 5.7 (0.000)
Mbd4 3.0 (0.005) 6.0 (0.000) 3.0 (0.004) 3.3 (0.000)
Rasgrf2 2.3 (0.002) 1.8 (0.006) 2.3 (0.001) 1.5 (0.040)
doi: 10.1371/journal.pone.0076865.t003
Table 4. Genes showing statistically significant (P < 0.05)
mRNA expression differences between tp0 and tp1 in at
least one of the study groups but not in the control group
(Mlh1+/+ AIN).
 Mlh1+/+ AIN Mlh1+/- AIN Mlh1+/+ WD Mlh1+/- WD
Downregulate
Genes
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Dkk1 2.0 (0.110) 5.1 (0.012) 6.2 (0.003) 7.3 (0.003)
Slc5a8 1.3 (0.078) 1.7 (0.041) 1.3 (0.224) 1.5 (0.032)
Hoxd1 1.1 (0.348) 2.0 (0.075) 2.1 (0.019) 1.5 (0.191)
Socs1 1.6 (0.460) 2.7 (0.067) 1.0 (0.485) 3.1 (0.026)
Upregulated
Genes
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Fold Change
(P)
Dkk2 2.2 (0.108) 2.2 (0.037) 1.7 (0.329) 1.0 (0.637)
Rprm 1.4 (0.442) 2.0 (0.017) 1.1 (0.725) 3.3 (0.019)
Acaa1b 2.4 (0.120) 1.8 (0.140) 3.5 (0.124) 9.4 (0.000)
doi: 10.1371/journal.pone.0076865.t004
Acaa1b showed a significant expression increase in the Mlh1+/-
WD* mice (9.4 fold) and the expression levels revealed a
significant difference (5.0 fold) when the Mlh1+/- WD* mice were
compared to the Mlh1+/- AIN group at tp1 (Table S5).
There were no available tissue samples/extracts to validate
the results at the protein level. Therefore, TaqMan RT-qPCR
was used to validate expression changes associated with the
cancer-predisposing Mlh1 mutation and/or WD*. The isogenic
background and our own results that mice showed similar
mRNA expression patterns at the outset (Figure S2A, S2B)
made it justified to combine the individual samples (n = 8) from
each group into pools for a subsequent use in the validation
experiments. Figure 1 illustrates differences observed between
the study groups and the control group at tp1.
The TaqMan assays confirmed the observation that Dkk1 is
one of the most prominent candidates with expression in colon
mucosa altered in association with inherited cancer
predisposition and WD*. Due to the low levels of Dkk1 mRNA,
RT-qPCR was performed on pre-amplified cDNA (amplification
uniformity value of -0.76). Dkk1 mRNA levels were significantly
decreased as compared to the control group (Mlh1+/+ AIN) in all
study groups [Mlh1+/+ WD*, 1.5 fold (range, 1.4–1.7); Mlh1+/-
AIN, 1.4 (1.3–1.5); Mlh1+/- WD*, 1.2 (1.1–1.2)] (Figure 1B). The
expression of Hoxd1 was significantly decreased not only in
Mlh1+/+ WD* mice [1.9 (1.7–2.2)], a finding already observed in
StellARray, but also in the Mlh1+/- WD* group [1.3 (1.2–1.3)]
(Figure 1D), highlighting the effect of WD* on Hoxd1
expression. The TaqMan RT-qPCR also confirmed the
importance of WD* on the expression of Dkk2, where in
StellARray a statistically significant decrease was seen in
Mlh1+/- WD* mice [1.2, (1.2–1.3)], but now also in WT mice fed
with WD* [1.2 (1.2–1.3), P = 0.053] (Figure 1F). The expression
of Acaa1b was also found to be significantly increased both in
the Mlh1+/- WD* and Mlh1+/+ WD* mice [2.6 (2.3–2.8) and 1.7
(1.7–1.8), respectively] (Figure S3). The expression levels of
Slc5a8 and Socs1 did not differ between the control group and
the study groups (Figure 1C, E).
Notably, no significant age or diet related expression
changes were found in Apc or Mlh1. Like at the start, the
expression of Mlh1 was approximately 50% lower in the
heterozygote mice compared to WT mice, indicating that the
second inactivating hit of Mlh1 had not yet occurred by tp1
(Figure 1A). The expression of Apc was similar in both
genotypes (StellARray).
Significant increases in DNA methylation levels
accompany reduced expression of genes
The methylation levels of the CGIs of the genes which had
shown statistically significant decrease in mRNA expression in
association with Mlh1 heterozygosity and/or WD* (Dkk1,
Slc5a8, Hoxd1, and Socs1; Table 4) were analyzed individually
for each tp0 and tp1 mouse using Sequenom’s MassARRAY
EPITYPERTM system. Additionally, Mlh1, and Sfrp1 which had
shown age-related expression decrease of borderline
significance (1.4 fold, P = 0.06) in the Mlh1+/- WD* group (Table
S5) and is a well-known gene in CRC and Wnt signaling were
studied for methylation. For Dkk1, no UCSC annotated CGI
exists and the target area was defined using EMBOSS CpG
Diet-Induced Cancer-Predisposing Events in Colon
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Figure 1.  Validation of the mRNA expression changes that were associated with WD* and/or inherited Mlh1 mutation using
TaqMan assays.  Relative expression in different study groups (Mlh1+/- AIN, Mlh1+/+ WD*, and Mlh1+/- WD*) is compared to the
control group (Mlh1+/+ AIN). Each sample is a mixture of eight RNA samples from eight different tp1 mice belonging to each mouse
group. Data is presented as mean ± SEM (standard error of the mean) (n = 3), *significant difference compared to the control group.
Median permutation method, P < 0.05. (A) Mlh1 shows the same 50% expression difference between the genotypes as at the
starting point of the study. (B) Dkk1 is significantly down regulated in the study groups with WD* and/or Mlh1 heterozygosity. (C)
Slc5a8 does not show significant expression differences at tp1. (D) Hoxd1 is down regulated in association with WD* in both
genotypes; the down regulation being especially strong in the Mlh1+/+ WD group. (E) Socs1 does not show significant expression
differences at tp1. (F) Dkk2 is down regulated in association with WD* in both genotypes.
doi: 10.1371/journal.pone.0076865.g001
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Plot showing an area of unusual CG composition, which is
largely the same area analyzed previously in mice [26].
Within all studied CGIs, the methylation ratios varied widely
between the individual CpG units studied (Figure S4). We
therefore calculated the mean methylation values for the entire
target regions (i.e. average methylation values across all
qualified CpG units at each CGI) for each mouse, and these
values were used when comparing the methylation levels
between different mice groups (Table 5). Although the mean
methylation levels seemed to be low in general, with the
exception of Mlh1, mean methylation levels were statistically
significantly higher among tp1 mice as compared to tp0 mice,
which is in accordance with the observation that all other genes
but Mlh1 had shown age-related decrease in mRNA expression
(Table 4). Overall, mean methylation levels varied at tp0
between 3% and 8%, and at tp1 between 6% and 15%. The
mean methylation values were the lowest for Mlh1 (5,6%),
whereas the highest mean methylation values at tp1 were seen
in Dkk1 (14,7%) and Sfrp1 (14,9%).
Mice cluster into high and low methylation groups
depending on diet and/or inherited predisposition
The Non-metric Multi-Dimensional Scaling (NMDS) tool of
the Chipster software [25] showed that the tp0 and tp1 mice
segregated into different parts of the plots indicating
differences in their methylation levels. Differential clustering of
methylation at tp1 was confirmed using the Chipster’s
Dendrogam tool in which two distinct methylation clusters
(higher and lower methylation cluster, i.e. Group 1 (G1) and
Group 2 (G2), respectively) were observed in each CGI (Figure
2). Except for one mouse in Sfrp1 and in Socs1 (B214 and
B225, respectively) an identical set of 11 mice clustered into
the higher methylation group at CGIs of Dkk1, SLc5a8, Hoxd1,
Socs1, and Sfrp1 (Figure 2). Among them, only two belonged
to the control Mlh1+/+ AIN group (B211, and B214), while the
remaining nine mice had either the inherited predisposition to
CRC (B201, B212, B225, and B232) were fed with WD* (B204,
B219, B231) or had both risk factors (B215, B220). In addition
to these 11 mice another 7 mice (B233, B236, B237, B243,
B246, B248, and B252) belonged to the higher Dkk1
methylation group.
The mean methylation levels of the Group 1 mice differed
significantly from those of the Group 2 mice as well as from tp0
mice (Table 5). Also G2 mice differed significantly from tp0
mice in regard to Dkk1, Slc5a8, Hoxd1, and Sfrp1, while for
Socs1 and Mlh1 they had remarkably similar mean methylation
levels at both time points. In Mlh1, G1 mice had, however, a
significantly higher mean methylation level than mice in G2 and
at tp0 (9%, 4%, and 4%, respectively) (Table 5).
Table 5. Descriptive and comparative statistics of the methylation data of the genes, Dkk1, Slc5a8, Hoxd1, Socs1, Sfrp1 and
Mlh1, for mice at tp0 and tp1 and for Group 1 (G1) and Group 2 (G2) (higher and lower methylation cluster, respectively) at
tp1 and comparison of the mean methylation values between the different mouse groups.
Gene Mouse Group Mean SD Mdn Min Max Range tp0 vs. tp1a G1 vs. G2a tp0 vs. G1a tp0 vs. G2a
Dkk1 tp0 (n =15) 0.034 0.024 0.030 0.01 0.10 0.09 0.000 0.000 0.000 0.000
 tp1 (n =32) 0.147 0.075 0.120 0.07 0.35 0.28     
 G1 (n =18) 0.187 0.078 0.160 0.10 0.35 0.25     
 G2 (n =14) 0.094 0.013 0.090 0.07 0.12 0.05     
Slc5a8 tp0 (n =15) 0.058 0.017 0.052 0.04 0.12 0.07 0.000 0.000 0.000 0.001
 tp1 (n =32) 0.090 0.044 0.068 0.05 0.21 0.15     
 G1 (n =11) 0.142 0.037 0.136 0.09 0.21 0.12     
 G2 (n =21) 0.063 0.008 0.062 0.05 0.08 0.03     
Hoxd1 tp0 (n =15) 0.037 0.008 0.040 0.02 0.05 0.03 0.000 0.000 0.000 0.000
 tp1 (n =32) 0.093 0.032 0.080 0.06 0.18 0.12     
 G1 (n =13) 0.119 0.021 0.120 0.08 0.15 0.07     
 G2 (n =18) 0.069 0.006 0.070 0.06 0.08 0.02     
Socs1 tp0 (n =15) 0.084 0.012 0.083 0.07 0.11 0.04 0.002 0.000 0.000 0.066
 tp1 (n =32) 0.107 0.028 0.093 0.08 0.17 0.10     
 G1 (n =10) 0.144 0.021 0.148 0.11 0.17 0.07     
 G2 (n =22) 0.091 0.008 0.091 0.08 0.11 0.04     
Sfrp1 tp0 (n =15) 0.071 0.014 0.067 0.05 0.10 0.05 0.000 0.000 0.000 0.000
 tp1 (n =32) 0.149 0.040 0.136 0.10 0.24 0.14     
 G1 (n =11) 0.189 0.040 0.198 0.12 0.24 0.12     
 G2 (n =19) 0.126 0.016 0.122 0.10 0.16 0.06     
Mlh1 tp0 (n =16) 0.040 0.016 0.036 0.02 0.09 0.07 0.089 0.000 0.000 0.776
 tp1 (n =31) 0.056 0.029 0.048 0.02 0.13 0.10     
 G1(n =9) 0.086 0.023 0.088 0.05 0.13 0.08     
 G2 (n =22) 0.043 0.021 0.037 0.02 0.11 0.08     
a P(Mann-Whitney test, Exact Sig., 2 tailed)
doi: 10.1371/journal.pone.0076865.t005
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Figure 2.  Methylation clusters and the NMDS analysis of the methylation data.  Using the Chipster’s Dendrogram tool, two
distinct clusters, the higher (Group 1) and the lower methylation cluster (Group 2) were observed at tp1. Except for one mouse in
Sfrp1 and in Socs1 (B214 and B225, respectively) the same 11 mice clustered into the higher methylation cluster at CGIs of Dkk1,
Slc5a8, Hoxd1, Socs1, and Sfrp1. The neoplasias are marked with superscripts ( ahyperplastic polyp, badenoma, cadenocarcinoma,
dnot histologically confirmed) and the mice groups with different colors (black; Mlh1+/+ AIN, brown; Mlh1+/- AIN, turquoise; Mlh1+/+
WD*, pink; Mlh1+/- WD*). Also according to the NMDS analysis (Chipster) the tp0 and tp1 mice segregate into different parts of the
plots indicating differences in their methylation levels. Red refers to tp0 mice, green refers to Group 1 mice, blue refers to Group 2
mice, and turquoise refers to mice that did not belong to either group.
doi: 10.1371/journal.pone.0076865.g002
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Expression and methylation changes are associated
with colonic neoplasia and pinpoint Dkk1 as a
promising biomarker
One proximal adenocarcinoma (B241, Mlh1+/+ WD) and five
adenomas/hyperplastic polyps (adenomas: B219, Mlh1+/+ WD;
B220, B236, Mlh1+/- WD and hyperplastic polyps: B215 Mlh1+/-
WD; B244, Mlh1+/- AIN) were observed in the 32 mice at tp1
and none of them occurred in the control mouse group. Four
out of six neoplasias were found in the mice showing higher
methylation at CGIs of all five genes Dkk1, Slc5a8, Hoxd1,
Socs1 and Sfrp1 (B219, B220), of the four genes Dkk1, Hoxd1,
Socs1 and Sfrp1 (B215), or of Dkk1 (B236) (Figure 2).
Dkk1 drew our particular attention, since 4 out of the 6
neoplasms were found in mice which showed Dkk1 inactivation
(Table 2). For Dkk1, up to 18 mice altogether clustered into the
Group 1, in which the mean methylation level was 18,7%,
whereas in the Group 2 it was 9,4% (Table 5, Figure 2). The
mRNA expression of Dkk1 was completely silenced in 16 mice
(B201, B204, B214, B215, B220, B225, B232, B233, B234,
B236, B241, B242, B249, B250, B252, and B253) and at least
in 10 cases hypermethylation was a plausible reason for its
inactivation (Figure 2).
Discussion
Our study was based on the presumption that along with
aging certain dietary components especially in Western-style
diet are important modifiers of methylation patterns in the colon
{Arasaradnam, 2008 #301} [8] and thus may affect the
transcription of genes involved in tumorigenesis. We further
reasoned that in mutation carriers requiring just a second hit of
the inherited susceptibility gene for malignant transformation, it
might be possible to detect the earliest changes, which might
even precede the second hit, and distinguish these from
alterations occurring later in oncogenesis. These hypotheses
proved valid when tested on a mouse model for Lynch
syndrome, the most common form of familial CRC.
The candidate gene approach was chosen instead of a
genome wide expression analysis in order to focus on
alterations already shown to be associated with human colon
cancer. Altogether, nine out of the 94 genes in the expression
array showed statistically significant age-related expression
changes in all mice groups, whereas statistically significant
expression changes related to Mlh1+/- and WD* were observed
for seven genes, and among those including expression
decreases in Dkk1, Slc5a8, Hoxd1, and Socs1 (Sfrp1 of
borderline significance). Many of the genes, which showed the
age-related expression and methylation changes in our study
associate with Wnt/β-catenin signaling, although, their changes
did not necessarily imply Wnt signaling activation as does the
expression decrease of Dkk1 and Sfrp1. The Wnt/β-catenin
signaling pathway is aberrantly activated in most human colon
cancers [27,28]. However, it has been recently found that a
number of Wnt signaling-related molecules are differently
expressed in the proximal and distal colon and suggested that
the proximal colon may constitute a unique signaling niche that
is more sensitive to Dkk1 signaling [29]. Indeed in the present
study on proximal colon mucosa, we did not observe changes
in the expression of Ctnnb1 (encoding β-catenin) or Apc, a
member of the β-catenin destruction complex in the cytosol [30]
however, the expression of Cdh1 (encoding cadherin 1, also
known as E- cadherin), which is a major component of
adherent junctions and binds to free cytosolic β-catenin [31]
was significantly decreased in all mouse groups, down
regulation being strongest in the Mlh1+/- WD* group. Dkk1 as
well as Sfrp1 are secreted Wnt signaling antagonists [32,33]
and act as “epigenetic gatekeepers”, whose aberrant silencing
may lock the cells into stem cell like states allowing time for
genetic gatekeeper mutations in the downstream pathway
genes to appear [32,34]. Here we observed a significant age-
related increase in methylation levels of Dkk1, Sfrp1, Slc5a8,
Hoxd1, and Socs1 CGIs but not of Mlh1, which was still well-
expressed at tp1, suggesting that expression decreases of the
other genes precede the involvement of Mlh1. Although Mlh1
methylation levels have been reported to increase with age in
normal colonic mucosa (characteristic of ‘type A’ genes)
[5,7,35-37], our results rather comply with studies [37,38]
classifying Mlh1 as a ‘type C’ gene, with methylation specificity
for neoplasia. Of the genes, for which we observed ‘type A’
methylation, Sfrp1 has previously been classified as a ‘type A’
gene, while Socs1 has been reported as a ‘type C’ gene [6].
Here, to our knowledge, the Wnt antagonist Dkk1 is for the
first time shown to be silenced already in histologically normal
colon mucosa. Contrary to human homologues DKK1 and
DKK2, whose silencing by CGI hypermethylation is indicated
both in colon cancer cell lines and gastrointestinal tumors
[33,39-41], Dkk1 downregulation in mice has been suggested
to occur through factors independent of DNA hypermethylation
[26]. The fact that majority of the mice not expressing Dkk1 in
their colon mucosa were Mlh1 heterozygotes (10/16) suggest a
link to haploinsufficiency caused by a loss of function mutation
in Mlh1. On the other hand, the decreased level of vitamin D3
(1.25(OH) 2D3), which has been shown to strongly regulate the
human DKK1 expression [28,42], may have contributed to the
decreased Dkk1 mRNA levels and colonic neoplasias in mice
fed with WD*. The importance of vitamin D3 in Dkk1 expression
and its regulation by epigenetic modification was further
supported in a recent study where its intake was negatively
associated with DKK1 methylation in a large cohort of CRCs
[41]. In our study, the mRNA expression of Dkk1 was
completely silenced in 16 mice and at least in 10 cases the
reason could have been hypermethylation.
Hoxd1 which is a target gene for Wnt [43] and Polycomb
Group (PcG) proteins [44] provides another illustrative example
of dietary effects. Hoxd1 has previously been reported to be
hypermethylated in a colon cancer cell line [45] and HOX gene
clusters in human lung carcinomas and in noncancerous lung
tissues [46]. Here, for the first time, we show that the
expression and methylation of Hoxd1 is altered already in
histologically normal colonic mucosa and especially in mice fed
with WD*, suggesting that dietary effects may create selective
pressure for its silencing.
Western diet has been reported to induce oxidative stress
responses and exert a pro-inflammatory stimulus in the colon
long before tumors occur [47]. Metabolic errors may in essence
initiate the epigenetic switch that contributes to carcinogenesis
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and cancer progression [48]. Changes that we observed in e.g.
Acaa1b and Socs1 may be related to inflammation and
alterations in energy metabolism. Furthermore, a mild
inflammation has been reported to accelerate colon
carcinogenesis in Mlh1-deficient mice [49], a finding in line with
our observation that most WD*-related alterations are linked to
Mlh1 heterozygosity.
In summary, among 73 TSGs, a specific set of genes and
Dkk1 in particular were identified as promising candidates for
altered methylation and expression, detectable already in
histologically normal mucosa and potentiated by an inherited
MMR gene mutation and Western-style diet. Such changes,
which are linked to human colon cancer and occur prior to the
second hit in the predisposing gene, may be among the very
earliest alterations in multistep tumorigenesis. Our results
highlight the interplay between genome, epigenome, and
environment in colon tumorigenesis and encourage studies to
explore the potential of the respective genes and alterations as
biomarkers for diagnostic, prognostic and therapeutic
applications in humans.
Supporting Information
Materials and Methods S1.  B6.129-Mlh1tm1Rak mice
genotyping. The Mlh1+/- and Mlh1+/+ mice were genotyped
using genomic DNA extracted from earmarks. Briefly, PCR
reaction contained primers M001 (5'-
TGTCAATAGGCTGCCCTAGG-3'; 0.33µM), M002 (5'-
TGGAAGGATTGGAGCTACGG-3'; 0.33µM), and M003 (5'-
TTTTCAGTGCAGCCTATGCTC-3'; 0.3µM), dNTP mix
(0.2mM), 1x reaction buffer, Dynazyme II (0.1 U/µL) (Thermo
Scientific, Finland), 50 ng of gDNA template, and MQ water in
a total volume of 20 µL. Cycling conditions were 94°C for 3
min, followed by 35 cycles of 94°C 1 min, 60°C 2 min, 72°C 1
min, and an elongation step 72°C 3 min. Primer combination
M001/M002 produced a 500 bp fragment indicating the mutant
allele, and combination M001/M003 produced a 350 bp
fragment indicating the wild-type allele.
(DOCX)
Figure S1.  Histological images of (A) A well-differentiated
colonic polypoid adenocarcinoma with focal (early)
invasion of the lamina propria (mouse B241 / Mlh1+/+ WD*)
and (B) A colonic adenoma (mouse B219 / Mlh1+/+ WD*). (4x
magnification, Olympus BX63).
(TIF)
Figure S2.  Comparison of mRNA expression patterns
between the Mlh1+/+ and Mlh1+/- mice at tp0. (A) Correlation
of the mean Cq values of the 94 genes included in the
StellARray between the tp0 mice with different Mlh1 genotypes
(n = 8). Pearson’s correlation, P = 0.000 (2-tailed). (B) Mlh1
expression of the Mlh1+/- mice is 50% of the expression level
detected in the Mlh1+/+ mice using TaqMan assay. Each sample
is a mixture of eight RNA samples from eight different tp0 mice
with the same Mlh1 genotype. Samples were ran in triplicate.
*Significant difference compared to the Mlh1+/+ group. Median
permutation method, P < 0.05.
(TIF)
Figure S3.  Validation of the StellARray mRNA expression
changes in Acaa1b that were associated with WD* and/or
inherited Mlh1 mutation using TaqMan assays. Relative
expression in different study groups (Mlh1+/- AIN, Mlh1+/+ WD*,
and Mlh1+/- WD*) compared to the control group (Mlh1+/+ AIN).
Each sample is a mixture of eight RNA samples from eight
different tp1 mice belonging to each mouse group. Data is
presented as mean ± s.e.m. (n = 3, each pooled sample were
ran triplicate), *significant difference compared to the control
group. Median permutation method, P < 0.05. Acaa1b shows
strong upregulation connected with WD* in both genotypes.
(TIF)
Figure S4.  Mean methylation at each qualified CpG unit at
CGIs of Mlh1, Dkk1, Slc5a8, Hoxd1, Socs1, and Sfrp1 for
the tp0 and tp1 mice separately. The mean methylation value
for each qualified CpG unit among the tp0 and tp1 mice is
presented with 95% confidence intervals.
(TIF)
Table S1.  Compositions of the experimental diets.
AIN-93G control diet is a semi-synthetic diet designed to meet
the nutritional requirements of growing rodents, while WD* is a
modified AIN diet, which contains high dietary fat (39% of total
calories) and reduced contents of fiber, calcium, vitamin D, and
three methyl-transfer donors (i.e. folic acid, methionine, and
choline). WD* contains more sucrose and correspondingly less
complex carbohydrates than the control diet and its fat consists
mainly of milkfat, while in AIN-93G, the fat source is exclusively
soy bean oil. WD* resembles the previously published
Western-style diet [11,12], which was described to induce
neoplasms in the colon of normal C57BL/6 mice. Notably the
fat content of WD* is yet more similar to the actual fat content
consumed by Western populations.
(DOCX)
Table S2.  Genes included in StellARray.
(DOCX)
Table S3.  TaqMan assays for studied genes.
(DOCX)
Table S4.  Amplicon data for methylation analyses.
(DOCX)
Table S5.  GPR results of expression differences between
different mice groups for the 94 genes studied.
(DOCX)
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